Abstract. Leptin receptors are distributed throughout the body and leptin has been shown to have various effects. As we have recently demonstrated a positive correlation between serum leptin levels and TSH in euthyroid subjects, we investigated the effect of leptin on the thyroids. It was observed that serum leptin levels were negatively correlated with free thyroxine/TSH ratios in the serum of euthyroid female subjects. This suggests that leptin may modulate TSH effects. RT-PCR for leptin receptor expression revealed that FRTL-5 cells possess the gene transcript to the long cytoplasmic form of the receptor. Leptin actually appeared to induce an increase in c-fos mRNA expression. However, it inhibited iodide uptake typically induced by both TSH and dibutyryl cAMP, while leptin did not inhibit TSH-induced cAMP production or TSH-stimulated DNA synthesis in 4H medium (in the absence of insulin and TSH). Leptin also was observed to inhibit TSH-and dibutyryl cAMP-induced Na + /I -symporter and thyroglobulin mRNA expression. Lastly, leptin was seen to inhibit TSH-stimulated thymidine incorporation in 5H medium. Taken together, these results suggest that leptin suppresses TSH-induced thyroid function. Therefore, we hypothesized that leptin may be one of the regulators of thyroid function in obese patients. LEPTIN, the gene product of the ob gene, is produced by fat tissues and acts in an endocrine fashion by reporting the size of the adipose tissue mass to hypothalamic leptin receptors that ultimately control the appetite and energy expenditure [1] . Recent studies show that leptin receptors are widely distributed throughout the body and that they have a variety of effects on a number of tissues. For example, functional leptin receptors are expressed in the ovary where leptin mediates the signal between fat storage and the reproductive system [2] . As for the thyroid, we earlier demonstrated a positive relation between serum leptin and TSH levels in euthyroid subjects [3] . In addition to our data, Wesche et al. reported that in obese subjects a larger thyroid size was associated with slightly but significantly higher TSH and lower free thyroxine (fT 4 ) serum levels [4] . As serum leptin concentrations positively correlate with body fat mass or body mass index, serum leptin levels should be higher in the obese subjects. We therefore assumed that leptin stimulates proliferation of thyroid cells or inhibits thyroid hormone synthesis stimulated by TSH in obese subjects by some mechanism. In order to clarify the possible role of leptin in regulation of thyroid function, we first analyzed the relation between serum leptin concentrations and fT 4 /TSH ratio in order to re-confirm the clinical relationship between obesity and thyroid function in euthyroid subjects. Next we investigated the direct actions of leptin on
LEPTIN, the gene product of the ob gene, is produced by fat tissues and acts in an endocrine fashion by reporting the size of the adipose tissue mass to hypothalamic leptin receptors that ultimately control the appetite and energy expenditure [1] . Recent studies show that leptin receptors are widely distributed throughout the body and that they have a variety of effects on a number of tissues. For example, functional leptin receptors are expressed in the ovary where leptin mediates the signal between fat storage and the reproductive system [2] . As for the thyroid, we earlier demonstrated a positive relation between serum leptin and TSH levels in euthyroid subjects [3] . In addition to our data, Wesche et al. reported that in obese subjects a larger thyroid size was associated with slightly but significantly higher TSH and lower free thyroxine (fT 4 ) serum levels [4] . As serum leptin concentrations positively correlate with body fat mass or body mass index, serum leptin levels should be higher in the obese subjects. We therefore assumed that leptin stimulates proliferation of thyroid cells or inhibits thyroid hormone synthesis stimulated by TSH in obese subjects by some mechanism. In order to clarify the possible role of leptin in regulation of thyroid function, we first analyzed the relation between serum leptin concentrations and fT 4 /TSH ratio in order to re-confirm the clinical relationship between obesity and thyroid function in euthyroid subjects. Next we investigated the direct actions of leptin on thyroid cell proliferation and thyroid cell function using a clonal rat thyroid cell line, FRTL-5. As a first step to the investigation on the direct interaction between leptin and thyroid follicular cells, we studied the functional leptin receptor expression in thyroid cells. We employed RT-PCR for detection of the active form of leptin receptor gene transcripts as shorter forms of receptors have only ligand binding domains and have no signal transduction system [5] . As a second step, we studied leptin-induced c-fos gene induction, which is one of the early responses to bioactive signals related to both cell proliferation and differentiated functions in thyroid cells [6] . After these basic studies, we then investigated the effects of leptin on differentiated functions and cell proliferation in order to clarify the possible role of leptin on thyroid hormone regulation and thyroid size in obese subjects. In this paper we present the inhibitory effects of leptin on iodine metabolism in FRTL-5 cells and further clarified the mechanism of the actions including inhibition of Na + /Isymporter (NIS) gene expression that is the initial step of thyroid hormone synthesis. We also present data on the effects of leptin on DNA synthesis. After presentation of these data, we discuss the possible roles of leptin in regulation of thyroid functions not only in obesity but also in critical illnesses because we must be careful when interpreting laboratory data on thyroid function especially in the latter condition.
Materials and Methods
Determination of leptin levels in non-obese subjects without thyroid disease Correlations between serum leptin, fT 4 and TSH levels were investigated in 61 euthyroid female subjects without thyroid disease as established in a previous study where anti-thyroid and anti-microsome antibodies were screened and found to be negative in these patients. Serum leptin levels in these patients were determined by a commercial RIA kit (Linco Research Inc., St. Charles, MO, USA). Serum TSH levels were determined by an IRMA kit (Daiichi RI, Tokyo, Japan) and free T 4 levels were measured by a RIA kit (Daiichi RI, Tokyo, Japan). Blood samples were collected between 13:00-15:00 h in our outpatient clinic, and the serum was frozen at -80°C until analysis.
Cell culture
The FRTL-5 cells used in this study are a continuous strain of functioning epithelial cells derived from normal Fisher rat thyroids and obtained from Dr. L.D. Kohn, NIH, Bethesda, MD, USA through the Interthyroid Foundation (Baltimore, MD, USA). The cells were grown in Coon's modified Ham's F-12 medium (Gibco-Oriental, Tokyo, Japan), supplemented with 5% calf serum (CS) (Nakarai Co., Kyoto, Japan), and a six-hormone mixture (6H) containing bovine TSH (1 mU/ml), insulin 10 mg/ml, cortisol (0.4 ng/ml), transferrin (5 mg/ml), glycyl-L-histidyl-L-lysine acetate (10 ng/ml), and somatostatin (10 ng/ml). Recombinant mouse leptin was purchased from Pepro Tech EC L., UK. TSH was obtained as a bovine preparation from Sigma Chemical Co. (St Louis, MO, USA). Insulin and other chemicals or hormones were also from Sigma Chemical Co., unless otherwise indicated. Cells were grown in a 5% CO 2 -95% air atmosphere (37°C). At the start of each experiment the medium was shifted as indicated. The 5H medium in this paper contained insulin, cortisol, transferrin, GHL, somatostatin, and 0.2% calf serum. Insulin was further omitted in the 4H medium.
RT-PCR for the detection of leptin receptor mRNA
Total RNA was extracted from FRTL-5 cells grown in 6H medium using a commercial kit supplied by Qiagen, Hilden, Germany. One milligram of each RNA sample was combined with 0.25 mg of an oligodT 15 primer in 16 mL of RT buffer, heated to 95°C for 2 minutes, chilled on ice and incubated at 37°C for 30 minutes for annealing. The samples were then incubated at 37°C for 60 minutes with 100 U (0.5 mL) of M-MLV reverse transcriptase (RT; Gibco-BRL/Life Technologies, Gaithersburg, MD, USA) in a 20 mL reaction mixture. To one ml of the RT reaction mixture the following was added: 1.0 mL of 10x reaction buffer, 0.8 mL of 2.5 nM dNTPs, 1.0 mL of primer mixture (10 pmol each) and 0.05 mL (0.025 U) of Thermus aquaticus (Taq) DNA polymerase (Gibco-BRL/Life Technologies, Gaithersburg, MD, USA) and the total volume was adjusted to 10 mL with water. The samples were then cycle-incubated for 40 cycles by denaturation at 94°C for 30 seconds, annealing at 65°C for 30 seconds and extension at 72°C for 60 seconds. Primers for the rat leptin receptor (long cytoplasmic form) were from a previously reported sequence (GenBank accession number D84551). The forward primer (2019 to 2040 nt) sequence was 5'-TGT GAG GAG GTA TGT GGT G-3', and the reverse primer (2264 to 2285 nt) sequence was 5'-TCA TTA GGT GAC AGT GTC CAG G-3'. Eight mL of the PCR reaction was subsequently mixed with 2 mL of 5x stopdye solution, run on a 3% agarose gel and stained with ethidium bromide.
Northern blot analyses for c-fos, NIS and thyroglobulin (Tg) mRNA levels
The RNA samples were electrophoresed on a 1% agarose gel containing 0.66 M formaldehyde and blotted onto nylon filters (Amersham Biosciences, Little Chalfont Buckinghamshire, UK). The filters were hybridized using cDNA probes labeled with [ 32 P]deoxycytidine triphosphate (3,000 Ci/mmol; New England Nuclear, Boston, MA, USA). Probes were labeled by random priming resulting in a specific activity of 1 × 10 8 cpm/mg DNA. Following hybridization the filters were subjected to autoradiography. Hybridization was performed as reported [7] and quantitative analysis of the autoradiograph was performed by an image scanner (Sharp Corporation, Osaka, Japan) using NIH Image computer software (NIH, Bethesda, MD, USA). In order to compare the various autoradiographs, the background of each was arbitrarily set at zero and the levels of RNA were expressed as arbitrarily units (square pixels) for each mRNA. The rat thyroglobulin and actin probes were the same as in the previous report [7] and the v-fos cDNA probe was from Oncor (Gaithersburg, MD, USA). Rat NIS probe was from Dr. Shinji Kosugi (Kyoto University, Kyoto, Japan). Data given represent the mean values of three separate experiments unless otherwise indicated.
Iodide uptake
FRTL-5 cells were incubated for 2 days in 4H medium with 0.2% CS. After 48 hours, the cells were incubated for another 2 days in 4H medium supplemented with TSH or dibutyryl cAMP in the presence or absence of leptin (100 ng/ml). The cells were subsequently exposed to 0.2 mCi (0.37 KBq) Na[ 125 I] (3.7 GBq/ml: New England Nuclear, Boston, MA, USA) in 10 -8 M NaI with and without 1 mM of sodium perchlorate for 1 hour. After removing the medium, the cells were washed with HBSS, and solubilized with 1 M NaOH. The radioactivity in the aliquot was then counted using a liquid scintillation counter. Iodide uptake was defined as the differences of total intracellular radioactivity with and without sodium perchlorate.
Cell viability and cytotoxicity assay
cytotoxicity assay was carried out to ascertain the nonspecific cytotoxity of leptin as well as the numbers of cells after treatment with the indicated agents. FRTL-5 cells were plated on 96 well-plates and the cells were preincubated for 48 hours in 4H medium. The cells were then further incubated for 48 hours in the conditions indicated. After the treatment MTS reaction was carried out using a commercial kit (CellTiter96 AQueous Reagent kit; Promega Corporation, Madison, WI, USA) following manufacturer's instruction and the results were expressed by corrected absorbance at 490 nm.
Assays measuring cyclic AMP levels in cells
After growth to near confluency in 12-well-plates, FRTL-5 cells were shifted to 4H medium supplemented with 0.2% CS for 2 days. Cells were then further incubated in the presence or absence of leptin (100 ng/ ml) for another 48 hours. Acute TSH responsiveness was measured by replacing the medium with 500 ml of an HBSS solution containing 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 20 mM HEPES (pH 7.4), 0.1% BSA, and the indicated concentrations of TSH. After incubation at 37°C for 120 minutes, the reactions were terminated by addition of 500 ml of 20% trichloroacetic acid. Total cAMP was then extracted by the TCA solution and the concentrations of camp were determined by RIA, using commercial kits (New England Nuclear-DuPont, Boston, MA, USA).
[ 3 H] Thymidine incorporation into DNA FRTL-5 cells were preincubated for 2 days in 4H medium supplemented with 0.2% CS. The cells were then further incubated in either 4H or 5H medium supplemented with [ 3 H] thymidine (0.1 mCi) and TSH (100 mU/ml) in the presence or absence of leptin (100 ng/ml). After 3 days, the cells were washed twice with PBS (pH 7.4), precipitated with 10% trichloroacetic acid and solubilized with 0.5 ml of 1 N NaOH. The cell extracts were subsequently neutralized with 0.5 ml of 1 N HCl, and the radioactivity was measured in a liquid scintillation counter.
Statistical analysis
All data are expressed as the mean ± SD except where indicated. Significance (p<0.05) between experimental values was assessed by one-way ANOVA where appropriate. Simple correlations were assessed for serum leptin levels and fT 4 /TSH ratios. Calculations were carried out using StatView 4.5 software (Abacus Concepts, Inc., Berkeley, CA, USA). All experiments were repeated a minimum of three times with different cell preparations to evaluate biological variability.
Results
Correlation between serum leptin levels and free thyroxine (fT 4 )/TSH ratios As shown in Fig. 1 , a negative correlation was seen between log transformed leptin levels in euthyroid female subjects without thyroid disease and serum fT 4 /TSH ratios (r = -0.411, p = 0.001, n = 61). However, a significant negative correlation was not observed in euthyroid male subjects possibly due to the relatively small sample number. The correlation within the female subject group though, suggests that leptin modulates TSH responsiveness of thyroid cells. Therefore, we investigated the possible roles of leptin in thyroid cell function as follows. Fig. 1 . The relationship between serum leptin concentrations and free thyroxine (fT 4 )/TSH ratios in euthyroid female subjects without thyroid disease. As shown in the figure, log transformed leptin levels in euthyroid female subjects negatively correlated with serum fT 4 /TSH ratio (r = 0.411, P = 0.001). , of the three forms of the leptin receptor that have been reported, only the long cytoplasmic form (long) has the unique cytoplasmic domain that is essential for signal transduction. PCR primers were selected to amplify the cDNA specific for the cytoplasmic domain as illustrated in the panel. Total RNA was extracted from three different cell preparations and RT-PCR was performed as described in Materials and Methods. As shown in the right panel (B), in all three cell preparations the expected size band was detected for the PCR product of the long form of the receptor, (Lane 1 to 3) whereas in the absence of cDNA no PCR product was detected (Lane C). Lane M indicates DNA size markers.
Expression of the long cytoplasmic form of leptin receptor mRNA in FRTL-5 thyroid cells
In order to identify functional leptin receptor expression in thyroid cells, we analyzed leptin receptor mRNA expression by RT-PCR in FRTL-5 thyroid cells. As shown in the left panel (A) of Fig. 2 , more than three forms of leptin receptors were reported. The long cytoplasmic form (long) contains a cytoplasmic domain that is important for signal transduction, while the other forms are considered non-functional. Therefore, we used specific primers for the cytoplasmic domain of the receptor as described in Materials and Methods. As shown in the right panel (B) of Fig. 2 , we could detect the transcript for the long form of the leptin receptor in FRTL-5 cells in all of three different cell preparations. We could also detect the cytoplasmic domain of the leptin receptor in human thyroid tissues which were contaminated by non-thyroid cells (data not shown).
Effects of leptin on c-fos mRNA expression
FRTL-5 cells were incubated with recombinant mouse leptin (100 ng/ml) in order to investigate the functional effects of leptin on thyroid cells. As shown in Fig. 3 , addition of leptin to cell cultures transiently increased c-fos gene transcripts in a manner similar to TSH or other biological stimuli such as basic fibroblast growth factor, endothelin and oncostatin-M which activate thyroid cells [6, [8] [9] [10] . These results indicate that leptin receptors expressed in cultured thyroid cells can be functionally analyzed in vitro.
Effect of leptin on iodide uptake in FRTL-5 cells
As the clinical data supported a negative correlation between serum leptin levels and fT 4 /TSH ratios, this suggested that leptin may modulate TSH action. Therefore, we next studied the effect of leptin on iodide uptake by FRTL-5 thyroid cells. Fig. 4 demonstrates that leptin significantly reduced iodide uptake induced by 100 mU/ml TSH. As shown in the figure, 12-O-tetradecanoylphorbol-13-acetate (TPA), one of the activator of c-kinase also inhibited the TSHinduced iodide uptake as reported [7] . Such inhibitory effects of leptin were also observed in the iodide uptake induced by dibutyryl cAMP (data not shown).
In order to rule out non-specific cytotoxicity leptin on FRTL-5 cells we also carried out MTS assay. The collected absorbance of the cells treated with leptin showed no significant difference in 4H medium as shown in Table 1 .
Effect of leptin on NIS and Tg mRNA levels
In order to elucidate the inhibitory mechanism of leptin on iodide uptake by FRTL-5 thyroid cells, we next investigated the effects of leptin on the NIS gene.
As shown in Fig. 5 , leptin inhibited both NIS and Tg mRNA induction stimulated by TSH. However, leptin did not show cytotoxicity in 4H medium as shown in Table 1 . Dibutyryl cAMP-induced NIS mRNA expression was also examined. As shown in Fig. 6 , leptin inhibited the dibutyryl cAMP-induced NIS mRNA increase. These results suggest that leptin inhibits TSH-induced NIS mRNA increases at steps distal to cAMP production which is similar in mode to its inhibition of iodide uptake.
Effect of leptin on cAMP production and DNA synthesis induced by TSH We next investigated the effect of leptin on cAMP production. As shown in Fig. 7 , leptin-pretreatment MTS assays were carried out as described in Materials and Methods. The cells were treated with leptin (100 ng/ml) or/and TSH (100 mU/ml) as indicated in either 4H or 5H conditions. The values are corrected absorbance (means ± standard deviations) of quadruplicated determinations. NS indicated no statistically significant difference from the cells treated without leptin and * indicates statistically significant difference from the cells treated without leptin (p<0.05). did not inhibit the cAMP production induced by TSH. Rather, TSH-induced cAMP production was potentiated. Interestingly, leptin inhibited TSH-induced DNA synthesis, as measured by [ 3 H] thymidine incorporation, only in 5H medium (with high concentration of insulin) but not in 4H medium (Fig. 8) . These results additionally support our hypothesis that leptin inhibits TSH-induced iodide uptake and TSH-induced increases in NIS mRNA levels at steps distal to cAMP production, but not at the steps of cAMP production. The inhibitory effect of leptin under 5H medium conditions may indicate that leptin antagonizes the action of IGF-I on DNA synthesis. The inhibitory effect of leptin was also demonstrated under 5H medium by MTS assay as shown in Table 1 .
Discussion
Recent studies have revealed that adipose tissue produces a number of important hormones, growth factors and cytokines including leptin [1] , tumor necrosis factor (TNF)-a [11] , and interleukin (IL)-6 [12] . While leptin was originally isolated as a regulator of food intake and energy expenditure produced by fat tissue [1] , it was unexpectedly shown to play impor- Fig. 6 . Effect of leptin on dibutyryl cAMP-induced increases of Na + /I -symporter (NIS) mRNA levels. Cells were cultured for 48 hours in the absence of TSH (4H medium with 0.2% CS). Cells were subsequently exposed to fresh medium containing the agents as indicated. After 24 hours, total RNA was isolated and subjected to Northern blot analysis. A representative autoradiogram of NIS and actin mRNA levels. Similar results were obtained in two additional experiments using different cell preparations. The decrease in the NIS/actin mRNA ratio induced by leptin in the presence of TSH was statistically significant (p<0.05) after densitometric analysis (data not shown). Fig. 7 . Effect of leptin on TSH-induced cAMP production. Cells were incubated for 48 hours in 4H medium containing 0.2% CS with and without leptin. Subsequently, cells were stimulated with TSH as described in Materials and Methods, and the amount of cAMP produced was determined by RIA. The values are means ± SD of triplicate determinations in one representative experiment. Cyclic AMP production stimulated by the higher concentrations of TSH (10 to 100 mU/ml) was potentiated by leptin pretreatment. Similar results were obtained in two separate experiments. The cells were then exposed to fresh medium containing the agents listed. DNA synthesis was determined by 3 Hthymidine incorporation as described in Materials and Methods. Leptin (100 ng/ml) had no effect on TSH (100 mU/ml) induced DNA synthesis in 4H medium. However, TSH-induced DNA synthesis in 5H medium (with insulin) was inhibited significantly (p <0.05).
tant roles in angiogenesis [13] , immune function [14] , fertility [15] , and bone formation [16] , acting through central or peripheral pathways. Concerning thyroid function, leptin has been shown to modulate proTRH gene expression [17] but little is known about the direct effect of leptin on thyroid cells. In this paper we have shown that clonal rat thyroid cells have functional leptin receptors, and that leptin suppresses TSH-induced biological activity in these cells in vitro at steps downstream to cAMP production. The action of leptin on thyroid cells is very similar to that reported for oncostatin-M [10] , IL-6 [10] , TGF-b [18] and TNF-a [19, 20] . These cytokines are considered to be involved in the suppression of thyroid hormone production and metabolism in non-thyroid disease. It has been shown that both leptin and IL-6 levels in serum were increased in sepsis, one of the acute critical illnesses [21] where serum leptin levels are higher and IL-6 levels are lower in survivors of sepsis as compared to non-survivors [22] . The data indicate that higher leptin levels may maintain immune functions in such patients and contribute to the recovery from sepsis. Thus each cytokine has its own specific role in these critical conditions. Oncostatin-M levels are also reported to be significantly increased under these conditions [23] . Our laboratory has reported that this cytokine has potent inhibitory effects on iodine metabolism acting through its own receptor system [10] . A series of cytokines thus appears to participate in the response to environmental stress, such as sepsis, and each cytokine has its own role in preventing the destruction of the inner cellular environment. Under these conditions, leptin may alter thyroid hormone production and metabolism in order to promote the survival of the individual.
Serum leptin levels are also elevated in obese subjects because of the increase of fat tissue, which is one of the major sources of leptin. Wesche et al. reported that in obese subjects thyroid size is correlated to lean body mass, while TSH levels are significantly elevated, and serum T4 concentrations are decreased in comparison to non-obese subjects [4] . These observations strongly suggest that one or more factors produced by fat tissues in obese subjects may inhibit TSH action and thyroid hormone synthesis. In addition to leptin, TNF-a or IL-6 are potential candidates. TNF-a and IL-6 production in peripheral lymphocytes is reported to be increased both in obese subjects and in patients with anorexia nervosa [24] . However, the exact role of IL-6 production in obese subjects is not known. TNFa has been shown to play an important role in insulin resistance, and the production of TNF-a in adipose tissues is increased in obese subjects with insulin resistance [25] . TNF-a was also shown to inhibit thyroid specific gene expression such as NIS [20] and TSHinduced hydrogen peroxide production [19] . However, in one study, TNF-a production by subcutaneous adipose tissue was not demonstrated in obese subjects [26] . Thus, it is not conclusively known whether TNF-a alters thyroid hormone production in obese subjects without thyroid disease.
In conclusion, leptin may be one of the modulators of thyroid function in both obese subjects without thyroid disease and patients in critical condition. The exact mechanism of the action of leptin on thyroid function must be clarified by future studies. However, we should remain cautions when we assess thyroid function in patients with increased leptin levels, since they may suppress thyroid hormone synthesis by inhibiting iodide uptake and NIS gene expression, as demonstrated in this paper.
